You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RUNX1-RUNX1T1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +8 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Childrens Oncology Group
Jul 12, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

Recruiting
  • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +5 more
  • Biopsy
  • +7 more
  • Lewes, Delaware
  • +42 more
Mar 15, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With

Completed
Has Results
  • Acute Myeloid Leukemia
  • +7 more
  • Lewes, Delaware
  • +64 more
Aug 3, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Erlotinib Hydrochloride
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Dec 18, 2019

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Longitudinal Studies of Patient With FPDMM

Recruiting
  • Inherited Hematological Diseases
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Adolescents and Young Adults With Type 1 Diabetes (EMA-T1D)

    Recruiting
    • Type 1 Diabetes
    • Observational
    • Ann Arbor, Michigan
      University of Michigan
    Nov 10, 2023

    Advanced Breast Cancer, Breast Tumor Malignant Female Trial in Guangzhou (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

    Completed
    • Advanced Breast Cancer
    • Breast Neoplasm Malignant Female
    • AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Apr 11, 2023

    Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)

    Recruiting
    • Type 1 Diabetes
    • FAMS-T1D
    • Digital resources for diabetes
    • Salt Lake City, Utah
      University of Utah
    Apr 7, 2023

    Fabry Disease Trial in Bron, Lyon (T1 mapping measurement)

    Not yet recruiting
    • Fabry Disease
    • T1 mapping measurement
    • Bron, France
    • +1 more
    Jun 27, 2023

    T1 Urinary Bladder Cancer Trial in Vienna (Prospective registry)

    Recruiting
    • T1 Urinary Bladder Cancer
    • Prospective registry
    • Vienna, Austria
      Medical University of Vienna
    Mar 31, 2023

    Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Sep 25, 2023

    Type 1 Diabetes Trial in Seattle (Verapamil)

    Completed
    • Type 1 Diabetes
    • Seattle, Washington
      Benaroya Research Institute
    Apr 27, 2023

    Diabetes, Diabetes, Type 1, Lipohypertrophy Trial in Roma (Medtronic Extended Infusion Set)

    Completed
    • Diabetes
    • +2 more
    • Medtronic Extended Infusion Set
    • Roma, Italy
      Azienda Ospedaliera San Camillo Forlanini
    Oct 6, 2023

    Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)

    Not yet recruiting
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Four Week Self-Compassion Course
    • Tunbridge Wells, United Kingdom
      Salomons Institute for Applied Psychology, Canterbury Christ Chu
    Mar 1, 2023

    Type 1 Diabetes With Hypoglycemia Trial (DailyDose Smart Snack app, Dexcom G6 CGM)

    Not yet recruiting
    • Type 1 Diabetes Mellitus With Hypoglycemia
    • DailyDose Smart Snack app
    • Dexcom G6 CGM
    • (no location specified)
    Jul 21, 2023

    Diabetes, Type 1, Obesity, Childhood, Overweight Trial (Family-Based Treatment for T1D)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +3 more
    • Family-Based Treatment for T1D
    • (no location specified)
    Feb 23, 2023

    nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

    Recruiting
    • nk/T-cell Lymphoma
    • +2 more
    • XPO1 inhibitor
    • Beijing, Haidian, China
      ChinaPLAGH
    Apr 18, 2023

    Colorectal Cancer Trial

    Completed
    • Colorectal Cancer
      • (no location specified)
      Nov 8, 2023

      CX3CR1+T Cell Predict Immunotherapy Efficacy

      Recruiting
      • Non-small Cell Lung Cancer
      • PD-1 inhibitor based immunotherapy
      • Changsha, Hunan, China
      • +1 more
      Sep 19, 2023